CBD-THC Mixture Helped Brain Immune Cells Clear Alzheimer's Plaques in Mice
A 99:1 CBD:THC botanical mixture enhanced microglial clearance of amyloid plaques in Alzheimer's mice, but also increased anxiety and depression-like behaviors.
Quick Facts
What This Study Found
Chronic treatment (28 days) with CBD:THC (99:1) at 50 mg/kg twice daily in 5xFAD Alzheimer's mice enhanced microglial phagocytic activity and reduced amyloid peptide accumulation in neuritic plaques. However, the treatment also reduced locomotion, increased anxiety-like and depression-like behaviors, and had no effect on memory or motor coordination.
Key Numbers
50 mg/kg twice daily for 28 days. CBD:THC ratio 99:1. Enhanced microglial phagocytic activity by flow cytometry. Reduced amyloid accumulation by multiphoton microscopy. Increased anxiety and depression-like behaviors. No memory or motor coordination effects.
How They Did This
Male 5xFAD Alzheimer's mice treated with CBD:THC (99:1) 50 mg/kg subcutaneously twice daily for 28 days. Behavioral battery, protein expression analysis, flow cytometry for phagocytosis, and in vivo multiphoton microscopy for plaque imaging.
Why This Research Matters
This is one of the first studies to show cannabinoids can enhance the brain's own plaque-clearing mechanisms in a living Alzheimer's model. However, the behavioral side effects present a clear challenge for translation to human treatment.
The Bigger Picture
The dual finding of enhanced plaque clearance alongside worsened behavior epitomizes the challenge of cannabinoid therapeutics in neurodegeneration. The immune benefits may be achievable at lower doses that avoid behavioral side effects, but this needs testing.
What This Study Doesn't Tell Us
Only male mice studied. High subcutaneous dose (50 mg/kg BID) far exceeds typical human dosing. The 5xFAD model represents aggressive amyloid pathology, not all aspects of human Alzheimer's. 28-day treatment may be too short.
Questions This Raises
- ?Could lower doses maintain the plaque-clearing benefits without the behavioral side effects?
- ?Would oral administration produce the same immune effects?
Trust & Context
- Key Stat:
- Enhanced plaque clearance but increased anxiety/depression
- Evidence Grade:
- Well-designed preclinical study using advanced imaging (multiphoton microscopy), but only male mice and high doses limit translational relevance.
- Study Age:
- 2026 study.
- Original Title:
- Treatment with a botanical mixture of cannabidiol:Δ9-tetrahydrocannabinol enhances microglial phagocytosis and shapes amyloid plaques in a mouse model of Alzheimer's disease.
- Published In:
- Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 194, 118902 (2026)
- Authors:
- Ruiz de Martín Esteban, Samuel(2), Grande, M Teresa, Martínez-Relimpio, Ana M, Herráez-Aguilar, Diego, Mostany, Ricardo, Hillard, Cecilia J, Hind, William H, Romero, Julián
- Database ID:
- RTHC-08591
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Can CBD help clear Alzheimer's plaques?
In this mouse study, a CBD-dominant mixture enhanced the brain's immune cells (microglia) to better clear amyloid plaques. However, the same treatment worsened anxiety and depression behaviors.
Why is the CBD:THC ratio 99:1?
The formulation is CBD-dominant with a trace of THC. This reflects the growing interest in botanical mixtures that may have different effects than pure CBD or pure THC alone.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-08591APA
Ruiz de Martín Esteban, Samuel; Grande, M Teresa; Martínez-Relimpio, Ana M; Herráez-Aguilar, Diego; Mostany, Ricardo; Hillard, Cecilia J; Hind, William H; Romero, Julián. (2026). Treatment with a botanical mixture of cannabidiol:Δ9-tetrahydrocannabinol enhances microglial phagocytosis and shapes amyloid plaques in a mouse model of Alzheimer's disease.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 194, 118902. https://doi.org/10.1016/j.biopha.2025.118902
MLA
Ruiz de Martín Esteban, Samuel, et al. "Treatment with a botanical mixture of cannabidiol:Δ9-tetrahydrocannabinol enhances microglial phagocytosis and shapes amyloid plaques in a mouse model of Alzheimer's disease.." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026. https://doi.org/10.1016/j.biopha.2025.118902
RethinkTHC
RethinkTHC Research Database. "Treatment with a botanical mixture of cannabidiol:Δ9-tetrahy..." RTHC-08591. Retrieved from https://rethinkthc.com/research/ruiz-2026-treatment-with-a-botanical
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.